THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
152,957,072
Share change
+24,775,051
Total reported value
$978,874,720
Put/Call ratio
74%
Price per share
$6.40
Number of holders
127
Value change
+$151,271,708
Number of buys
82
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q1 2016

As of 31 Mar 2016, THERAPEUTICSMD INC - COM (TXMD) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 152,957,072 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Bank of New York Mellon Corp, FRANKLIN RESOURCES INC, JPMORGAN CHASE & CO, VANGUARD GROUP INC, GILDER GAGNON HOWE & CO LLC, BlackRock Fund Advisors, and BlackRock Institutional Trust Company, N.A.. This page lists 127 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.